nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—SLCO1C1—Methotrexate—lymphatic system cancer	0.0976	0.135	CbGbCtD
Diclofenac—ABCC1—Mitoxantrone—lymphatic system cancer	0.0904	0.125	CbGbCtD
Diclofenac—ABCC1—Vincristine—lymphatic system cancer	0.0622	0.0858	CbGbCtD
Diclofenac—CYP1A2—Carmustine—lymphatic system cancer	0.0531	0.0732	CbGbCtD
Diclofenac—SLC22A11—Methotrexate—lymphatic system cancer	0.0504	0.0695	CbGbCtD
Diclofenac—ABCC4—Methotrexate—lymphatic system cancer	0.0469	0.0647	CbGbCtD
Diclofenac—CYP2E1—Mitoxantrone—lymphatic system cancer	0.0432	0.0595	CbGbCtD
Diclofenac—CYP2C19—Teniposide—lymphatic system cancer	0.0387	0.0533	CbGbCtD
Diclofenac—ABCC1—Methotrexate—lymphatic system cancer	0.0377	0.052	CbGbCtD
Diclofenac—CYP2C9—Teniposide—lymphatic system cancer	0.0322	0.0443	CbGbCtD
Diclofenac—SLC22A8—Methotrexate—lymphatic system cancer	0.0293	0.0404	CbGbCtD
Diclofenac—ABCB1—Mitoxantrone—lymphatic system cancer	0.0218	0.0301	CbGbCtD
Diclofenac—SLC22A6—Methotrexate—lymphatic system cancer	0.0204	0.0281	CbGbCtD
Diclofenac—CYP3A4—Cytarabine—lymphatic system cancer	0.019	0.0262	CbGbCtD
Diclofenac—CYP3A4—Teniposide—lymphatic system cancer	0.0187	0.0258	CbGbCtD
Diclofenac—ALB—Methotrexate—lymphatic system cancer	0.0174	0.024	CbGbCtD
Diclofenac—ABCB1—Vincristine—lymphatic system cancer	0.015	0.0207	CbGbCtD
Diclofenac—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0131	0.018	CbGbCtD
Diclofenac—ABCB1—Methotrexate—lymphatic system cancer	0.00909	0.0125	CbGbCtD
Diclofenac—CYP3A4—Vincristine—lymphatic system cancer	0.009	0.0124	CbGbCtD
Diclofenac—Rash—Teniposide—lymphatic system cancer	0.000259	0.000941	CcSEcCtD
Diclofenac—Dermatitis—Teniposide—lymphatic system cancer	0.000258	0.00094	CcSEcCtD
Diclofenac—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000257	0.000936	CcSEcCtD
Diclofenac—Headache—Teniposide—lymphatic system cancer	0.000257	0.000935	CcSEcCtD
Diclofenac—Pruritus—Fludarabine—lymphatic system cancer	0.000255	0.000928	CcSEcCtD
Diclofenac—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000255	0.000927	CcSEcCtD
Diclofenac—Back pain—Mitoxantrone—lymphatic system cancer	0.000254	0.000925	CcSEcCtD
Diclofenac—Leukopenia—Carmustine—lymphatic system cancer	0.000253	0.00092	CcSEcCtD
Diclofenac—Anorexia—Bleomycin—lymphatic system cancer	0.000252	0.000916	CcSEcCtD
Diclofenac—Anaemia—Vincristine—lymphatic system cancer	0.000249	0.000907	CcSEcCtD
Diclofenac—Agitation—Vincristine—lymphatic system cancer	0.000248	0.000902	CcSEcCtD
Diclofenac—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000248	0.000901	CcSEcCtD
Diclofenac—Polyuria—Methotrexate—lymphatic system cancer	0.000248	0.000901	CcSEcCtD
Diclofenac—Photosensitivity—Methotrexate—lymphatic system cancer	0.000248	0.000901	CcSEcCtD
Diclofenac—Hypotension—Bleomycin—lymphatic system cancer	0.000247	0.000898	CcSEcCtD
Diclofenac—Diarrhoea—Fludarabine—lymphatic system cancer	0.000247	0.000897	CcSEcCtD
Diclofenac—Convulsion—Carmustine—lymphatic system cancer	0.000245	0.000891	CcSEcCtD
Diclofenac—Hypertension—Carmustine—lymphatic system cancer	0.000244	0.000888	CcSEcCtD
Diclofenac—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000244	0.000887	CcSEcCtD
Diclofenac—Nausea—Teniposide—lymphatic system cancer	0.000244	0.000886	CcSEcCtD
Diclofenac—Anaemia—Mitoxantrone—lymphatic system cancer	0.000243	0.000884	CcSEcCtD
Diclofenac—Vertigo—Vincristine—lymphatic system cancer	0.000243	0.000882	CcSEcCtD
Diclofenac—Hepatic failure—Methotrexate—lymphatic system cancer	0.000242	0.00088	CcSEcCtD
Diclofenac—Leukopenia—Vincristine—lymphatic system cancer	0.000242	0.000879	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000241	0.000876	CcSEcCtD
Diclofenac—Chest pain—Carmustine—lymphatic system cancer	0.000241	0.000875	CcSEcCtD
Diclofenac—Myalgia—Carmustine—lymphatic system cancer	0.000241	0.000875	CcSEcCtD
Diclofenac—Anxiety—Carmustine—lymphatic system cancer	0.00024	0.000872	CcSEcCtD
Diclofenac—Paraesthesia—Bleomycin—lymphatic system cancer	0.000237	0.000863	CcSEcCtD
Diclofenac—Malaise—Mitoxantrone—lymphatic system cancer	0.000237	0.000862	CcSEcCtD
Diclofenac—Dyspnoea—Bleomycin—lymphatic system cancer	0.000236	0.000857	CcSEcCtD
Diclofenac—Renal failure acute—Methotrexate—lymphatic system cancer	0.000236	0.000857	CcSEcCtD
Diclofenac—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000235	0.000856	CcSEcCtD
Diclofenac—Convulsion—Vincristine—lymphatic system cancer	0.000234	0.000851	CcSEcCtD
Diclofenac—Hypertension—Vincristine—lymphatic system cancer	0.000233	0.000848	CcSEcCtD
Diclofenac—Confusional state—Carmustine—lymphatic system cancer	0.000233	0.000846	CcSEcCtD
Diclofenac—Oedema—Carmustine—lymphatic system cancer	0.000231	0.000839	CcSEcCtD
Diclofenac—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.00023	0.000838	CcSEcCtD
Diclofenac—Decreased appetite—Bleomycin—lymphatic system cancer	0.00023	0.000836	CcSEcCtD
Diclofenac—Myalgia—Vincristine—lymphatic system cancer	0.00023	0.000836	CcSEcCtD
Diclofenac—Visual disturbance—Methotrexate—lymphatic system cancer	0.000229	0.000835	CcSEcCtD
Diclofenac—Cough—Mitoxantrone—lymphatic system cancer	0.000229	0.000834	CcSEcCtD
Diclofenac—Infection—Carmustine—lymphatic system cancer	0.000229	0.000834	CcSEcCtD
Diclofenac—Vomiting—Fludarabine—lymphatic system cancer	0.000229	0.000834	CcSEcCtD
Diclofenac—Convulsion—Mitoxantrone—lymphatic system cancer	0.000228	0.000828	CcSEcCtD
Diclofenac—Rash—Fludarabine—lymphatic system cancer	0.000227	0.000827	CcSEcCtD
Diclofenac—Dermatitis—Fludarabine—lymphatic system cancer	0.000227	0.000826	CcSEcCtD
Diclofenac—Hypertension—Mitoxantrone—lymphatic system cancer	0.000227	0.000825	CcSEcCtD
Diclofenac—Pain—Bleomycin—lymphatic system cancer	0.000226	0.000822	CcSEcCtD
Diclofenac—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000226	0.000822	CcSEcCtD
Diclofenac—Headache—Fludarabine—lymphatic system cancer	0.000226	0.000822	CcSEcCtD
Diclofenac—Tachycardia—Carmustine—lymphatic system cancer	0.000225	0.000819	CcSEcCtD
Diclofenac—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.000225	0.000817	CcSEcCtD
Diclofenac—Chest pain—Mitoxantrone—lymphatic system cancer	0.000224	0.000814	CcSEcCtD
Diclofenac—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000224	0.000814	CcSEcCtD
Diclofenac—Myalgia—Mitoxantrone—lymphatic system cancer	0.000224	0.000814	CcSEcCtD
Diclofenac—Anxiety—Mitoxantrone—lymphatic system cancer	0.000223	0.000811	CcSEcCtD
Diclofenac—Lethargy—Methotrexate—lymphatic system cancer	0.000222	0.000807	CcSEcCtD
Diclofenac—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000222	0.000807	CcSEcCtD
Diclofenac—Discomfort—Mitoxantrone—lymphatic system cancer	0.000221	0.000804	CcSEcCtD
Diclofenac—Oedema—Vincristine—lymphatic system cancer	0.00022	0.000801	CcSEcCtD
Diclofenac—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00022	0.000801	CcSEcCtD
Diclofenac—Anorexia—Carmustine—lymphatic system cancer	0.00022	0.0008	CcSEcCtD
Diclofenac—Infection—Vincristine—lymphatic system cancer	0.000219	0.000796	CcSEcCtD
Diclofenac—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000218	0.000792	CcSEcCtD
Diclofenac—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000217	0.000791	CcSEcCtD
Diclofenac—Confusional state—Mitoxantrone—lymphatic system cancer	0.000216	0.000787	CcSEcCtD
Diclofenac—Nervous system disorder—Vincristine—lymphatic system cancer	0.000216	0.000786	CcSEcCtD
Diclofenac—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000216	0.000784	CcSEcCtD
Diclofenac—Hypotension—Carmustine—lymphatic system cancer	0.000216	0.000784	CcSEcCtD
Diclofenac—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000215	0.00078	CcSEcCtD
Diclofenac—Oedema—Mitoxantrone—lymphatic system cancer	0.000215	0.00078	CcSEcCtD
Diclofenac—Nausea—Fludarabine—lymphatic system cancer	0.000214	0.000779	CcSEcCtD
Diclofenac—Infection—Mitoxantrone—lymphatic system cancer	0.000213	0.000775	CcSEcCtD
Diclofenac—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000213	0.000775	CcSEcCtD
Diclofenac—Shock—Mitoxantrone—lymphatic system cancer	0.000211	0.000768	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00021	0.000765	CcSEcCtD
Diclofenac—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00021	0.000764	CcSEcCtD
Diclofenac—Urticaria—Bleomycin—lymphatic system cancer	0.00021	0.000764	CcSEcCtD
Diclofenac—Anorexia—Vincristine—lymphatic system cancer	0.00021	0.000764	CcSEcCtD
Diclofenac—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000209	0.000761	CcSEcCtD
Diclofenac—Body temperature increased—Bleomycin—lymphatic system cancer	0.000209	0.00076	CcSEcCtD
Diclofenac—Insomnia—Carmustine—lymphatic system cancer	0.000209	0.000759	CcSEcCtD
Diclofenac—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000208	0.000758	CcSEcCtD
Diclofenac—Irritability—Methotrexate—lymphatic system cancer	0.000208	0.000755	CcSEcCtD
Diclofenac—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000207	0.000754	CcSEcCtD
Diclofenac—Paraesthesia—Carmustine—lymphatic system cancer	0.000207	0.000754	CcSEcCtD
Diclofenac—Hypotension—Vincristine—lymphatic system cancer	0.000206	0.000749	CcSEcCtD
Diclofenac—Dyspnoea—Carmustine—lymphatic system cancer	0.000206	0.000748	CcSEcCtD
Diclofenac—Somnolence—Carmustine—lymphatic system cancer	0.000205	0.000746	CcSEcCtD
Diclofenac—Anorexia—Mitoxantrone—lymphatic system cancer	0.000204	0.000744	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000201	0.00073	CcSEcCtD
Diclofenac—Decreased appetite—Carmustine—lymphatic system cancer	0.000201	0.00073	CcSEcCtD
Diclofenac—Hypotension—Mitoxantrone—lymphatic system cancer	0.0002	0.000729	CcSEcCtD
Diclofenac—Insomnia—Vincristine—lymphatic system cancer	0.000199	0.000725	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000199	0.000725	CcSEcCtD
Diclofenac—Paraesthesia—Vincristine—lymphatic system cancer	0.000198	0.000719	CcSEcCtD
Diclofenac—Pain—Carmustine—lymphatic system cancer	0.000197	0.000718	CcSEcCtD
Diclofenac—Constipation—Carmustine—lymphatic system cancer	0.000197	0.000718	CcSEcCtD
Diclofenac—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000196	0.000712	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000195	0.000711	CcSEcCtD
Diclofenac—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000195	0.000708	CcSEcCtD
Diclofenac—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000193	0.000701	CcSEcCtD
Diclofenac—Decreased appetite—Vincristine—lymphatic system cancer	0.000191	0.000696	CcSEcCtD
Diclofenac—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000191	0.000696	CcSEcCtD
Diclofenac—Somnolence—Mitoxantrone—lymphatic system cancer	0.000191	0.000694	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00019	0.000692	CcSEcCtD
Diclofenac—Feeling abnormal—Carmustine—lymphatic system cancer	0.00019	0.000692	CcSEcCtD
Diclofenac—Fatigue—Vincristine—lymphatic system cancer	0.00019	0.000691	CcSEcCtD
Diclofenac—Asthenia—Bleomycin—lymphatic system cancer	0.00019	0.00069	CcSEcCtD
Diclofenac—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000189	0.000687	CcSEcCtD
Diclofenac—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000189	0.000686	CcSEcCtD
Diclofenac—Constipation—Vincristine—lymphatic system cancer	0.000188	0.000685	CcSEcCtD
Diclofenac—Pain—Vincristine—lymphatic system cancer	0.000188	0.000685	CcSEcCtD
Diclofenac—Asthma—Methotrexate—lymphatic system cancer	0.000188	0.000684	CcSEcCtD
Diclofenac—Pruritus—Bleomycin—lymphatic system cancer	0.000187	0.00068	CcSEcCtD
Diclofenac—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000186	0.000678	CcSEcCtD
Diclofenac—Eosinophilia—Methotrexate—lymphatic system cancer	0.000186	0.000677	CcSEcCtD
Diclofenac—Fatigue—Mitoxantrone—lymphatic system cancer	0.000185	0.000673	CcSEcCtD
Diclofenac—Pancreatitis—Methotrexate—lymphatic system cancer	0.000184	0.00067	CcSEcCtD
Diclofenac—Pain—Mitoxantrone—lymphatic system cancer	0.000183	0.000667	CcSEcCtD
Diclofenac—Constipation—Mitoxantrone—lymphatic system cancer	0.000183	0.000667	CcSEcCtD
Diclofenac—Abdominal pain—Carmustine—lymphatic system cancer	0.000182	0.000663	CcSEcCtD
Diclofenac—Body temperature increased—Carmustine—lymphatic system cancer	0.000182	0.000663	CcSEcCtD
Diclofenac—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.00018	0.000655	CcSEcCtD
Diclofenac—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00018	0.000655	CcSEcCtD
Diclofenac—Pancytopenia—Methotrexate—lymphatic system cancer	0.000179	0.000649	CcSEcCtD
Diclofenac—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000177	0.000643	CcSEcCtD
Diclofenac—Dysuria—Methotrexate—lymphatic system cancer	0.000176	0.000639	CcSEcCtD
Diclofenac—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000175	0.000638	CcSEcCtD
Diclofenac—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000175	0.000635	CcSEcCtD
Diclofenac—Abdominal pain—Vincristine—lymphatic system cancer	0.000174	0.000633	CcSEcCtD
Diclofenac—Body temperature increased—Vincristine—lymphatic system cancer	0.000174	0.000633	CcSEcCtD
Diclofenac—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000173	0.00063	CcSEcCtD
Diclofenac—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000172	0.000624	CcSEcCtD
Diclofenac—Urticaria—Mitoxantrone—lymphatic system cancer	0.00017	0.00062	CcSEcCtD
Diclofenac—Hypersensitivity—Carmustine—lymphatic system cancer	0.00017	0.000618	CcSEcCtD
Diclofenac—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00017	0.000617	CcSEcCtD
Diclofenac—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00017	0.000617	CcSEcCtD
Diclofenac—Pneumonia—Methotrexate—lymphatic system cancer	0.000169	0.000613	CcSEcCtD
Diclofenac—Vomiting—Bleomycin—lymphatic system cancer	0.000168	0.000611	CcSEcCtD
Diclofenac—Infestation—Methotrexate—lymphatic system cancer	0.000168	0.00061	CcSEcCtD
Diclofenac—Drowsiness—Methotrexate—lymphatic system cancer	0.000168	0.00061	CcSEcCtD
Diclofenac—Infestation NOS—Methotrexate—lymphatic system cancer	0.000168	0.00061	CcSEcCtD
Diclofenac—Depression—Methotrexate—lymphatic system cancer	0.000167	0.000608	CcSEcCtD
Diclofenac—Rash—Bleomycin—lymphatic system cancer	0.000167	0.000606	CcSEcCtD
Diclofenac—Dermatitis—Bleomycin—lymphatic system cancer	0.000167	0.000606	CcSEcCtD
Diclofenac—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000166	0.000604	CcSEcCtD
Diclofenac—Asthenia—Carmustine—lymphatic system cancer	0.000166	0.000602	CcSEcCtD
Diclofenac—Renal failure—Methotrexate—lymphatic system cancer	0.000165	0.000599	CcSEcCtD
Diclofenac—Stomatitis—Methotrexate—lymphatic system cancer	0.000163	0.000594	CcSEcCtD
Diclofenac—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000163	0.000592	CcSEcCtD
Diclofenac—Hypersensitivity—Vincristine—lymphatic system cancer	0.000162	0.00059	CcSEcCtD
Diclofenac—Sweating—Methotrexate—lymphatic system cancer	0.000161	0.000584	CcSEcCtD
Diclofenac—Haematuria—Methotrexate—lymphatic system cancer	0.00016	0.000581	CcSEcCtD
Diclofenac—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000158	0.000576	CcSEcCtD
Diclofenac—Epistaxis—Methotrexate—lymphatic system cancer	0.000158	0.000575	CcSEcCtD
Diclofenac—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000158	0.000575	CcSEcCtD
Diclofenac—Asthenia—Vincristine—lymphatic system cancer	0.000158	0.000575	CcSEcCtD
Diclofenac—Diarrhoea—Carmustine—lymphatic system cancer	0.000158	0.000574	CcSEcCtD
Diclofenac—Nausea—Bleomycin—lymphatic system cancer	0.000157	0.000571	CcSEcCtD
Diclofenac—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000156	0.000569	CcSEcCtD
Diclofenac—Asthenia—Mitoxantrone—lymphatic system cancer	0.000154	0.00056	CcSEcCtD
Diclofenac—Dizziness—Carmustine—lymphatic system cancer	0.000153	0.000555	CcSEcCtD
Diclofenac—Haemoglobin—Methotrexate—lymphatic system cancer	0.000151	0.00055	CcSEcCtD
Diclofenac—Diarrhoea—Vincristine—lymphatic system cancer	0.000151	0.000548	CcSEcCtD
Diclofenac—Haemorrhage—Methotrexate—lymphatic system cancer	0.00015	0.000547	CcSEcCtD
Diclofenac—Hepatitis—Methotrexate—lymphatic system cancer	0.00015	0.000547	CcSEcCtD
Diclofenac—Pharyngitis—Methotrexate—lymphatic system cancer	0.000149	0.000543	CcSEcCtD
Diclofenac—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000149	0.00054	CcSEcCtD
Diclofenac—Urethral disorder—Methotrexate—lymphatic system cancer	0.000147	0.000536	CcSEcCtD
Diclofenac—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000147	0.000534	CcSEcCtD
Diclofenac—Vomiting—Carmustine—lymphatic system cancer	0.000147	0.000534	CcSEcCtD
Diclofenac—Dizziness—Vincristine—lymphatic system cancer	0.000146	0.00053	CcSEcCtD
Diclofenac—Rash—Carmustine—lymphatic system cancer	0.000145	0.000529	CcSEcCtD
Diclofenac—Dermatitis—Carmustine—lymphatic system cancer	0.000145	0.000529	CcSEcCtD
Diclofenac—Visual impairment—Methotrexate—lymphatic system cancer	0.000145	0.000527	CcSEcCtD
Diclofenac—Headache—Carmustine—lymphatic system cancer	0.000145	0.000526	CcSEcCtD
Diclofenac—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000142	0.000517	CcSEcCtD
Diclofenac—Eye disorder—Methotrexate—lymphatic system cancer	0.000141	0.000511	CcSEcCtD
Diclofenac—Tinnitus—Methotrexate—lymphatic system cancer	0.00014	0.00051	CcSEcCtD
Diclofenac—Vomiting—Vincristine—lymphatic system cancer	0.00014	0.000509	CcSEcCtD
Diclofenac—Cardiac disorder—Methotrexate—lymphatic system cancer	0.00014	0.000508	CcSEcCtD
Diclofenac—Rash—Vincristine—lymphatic system cancer	0.000139	0.000505	CcSEcCtD
Diclofenac—Dermatitis—Vincristine—lymphatic system cancer	0.000139	0.000505	CcSEcCtD
Diclofenac—Headache—Vincristine—lymphatic system cancer	0.000138	0.000502	CcSEcCtD
Diclofenac—Nausea—Carmustine—lymphatic system cancer	0.000137	0.000499	CcSEcCtD
Diclofenac—Angiopathy—Methotrexate—lymphatic system cancer	0.000136	0.000496	CcSEcCtD
Diclofenac—Vomiting—Mitoxantrone—lymphatic system cancer	0.000136	0.000496	CcSEcCtD
Diclofenac—Immune system disorder—Methotrexate—lymphatic system cancer	0.000136	0.000494	CcSEcCtD
Diclofenac—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000136	0.000493	CcSEcCtD
Diclofenac—Rash—Mitoxantrone—lymphatic system cancer	0.000135	0.000492	CcSEcCtD
Diclofenac—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000135	0.000491	CcSEcCtD
Diclofenac—Chills—Methotrexate—lymphatic system cancer	0.000135	0.000491	CcSEcCtD
Diclofenac—Headache—Mitoxantrone—lymphatic system cancer	0.000134	0.000489	CcSEcCtD
Diclofenac—Alopecia—Methotrexate—lymphatic system cancer	0.000133	0.000484	CcSEcCtD
Diclofenac—Mental disorder—Methotrexate—lymphatic system cancer	0.000132	0.000479	CcSEcCtD
Diclofenac—Malnutrition—Methotrexate—lymphatic system cancer	0.000131	0.000476	CcSEcCtD
Diclofenac—Erythema—Methotrexate—lymphatic system cancer	0.000131	0.000476	CcSEcCtD
Diclofenac—Nausea—Vincristine—lymphatic system cancer	0.000131	0.000476	CcSEcCtD
Diclofenac—Dysgeusia—Methotrexate—lymphatic system cancer	0.000128	0.000466	CcSEcCtD
Diclofenac—Nausea—Mitoxantrone—lymphatic system cancer	0.000127	0.000463	CcSEcCtD
Diclofenac—Back pain—Methotrexate—lymphatic system cancer	0.000127	0.000461	CcSEcCtD
Diclofenac—Vision blurred—Methotrexate—lymphatic system cancer	0.000123	0.000449	CcSEcCtD
Diclofenac—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000122	0.000442	CcSEcCtD
Diclofenac—Anaemia—Methotrexate—lymphatic system cancer	0.000121	0.00044	CcSEcCtD
Diclofenac—Malaise—Methotrexate—lymphatic system cancer	0.000118	0.00043	CcSEcCtD
Diclofenac—Vertigo—Methotrexate—lymphatic system cancer	0.000118	0.000428	CcSEcCtD
Diclofenac—Leukopenia—Methotrexate—lymphatic system cancer	0.000117	0.000426	CcSEcCtD
Diclofenac—Cough—Methotrexate—lymphatic system cancer	0.000114	0.000416	CcSEcCtD
Diclofenac—Convulsion—Methotrexate—lymphatic system cancer	0.000113	0.000413	CcSEcCtD
Diclofenac—Chest pain—Methotrexate—lymphatic system cancer	0.000111	0.000406	CcSEcCtD
Diclofenac—Myalgia—Methotrexate—lymphatic system cancer	0.000111	0.000406	CcSEcCtD
Diclofenac—Arthralgia—Methotrexate—lymphatic system cancer	0.000111	0.000406	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000111	0.000403	CcSEcCtD
Diclofenac—Discomfort—Methotrexate—lymphatic system cancer	0.00011	0.000401	CcSEcCtD
Diclofenac—Confusional state—Methotrexate—lymphatic system cancer	0.000108	0.000392	CcSEcCtD
Diclofenac—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000107	0.000389	CcSEcCtD
Diclofenac—Infection—Methotrexate—lymphatic system cancer	0.000106	0.000386	CcSEcCtD
Diclofenac—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000105	0.000381	CcSEcCtD
Diclofenac—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000105	0.000381	CcSEcCtD
Diclofenac—Skin disorder—Methotrexate—lymphatic system cancer	0.000104	0.000378	CcSEcCtD
Diclofenac—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000103	0.000376	CcSEcCtD
Diclofenac—Anorexia—Methotrexate—lymphatic system cancer	0.000102	0.000371	CcSEcCtD
Diclofenac—Hypotension—Methotrexate—lymphatic system cancer	9.99e-05	0.000363	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	9.74e-05	0.000354	CcSEcCtD
Diclofenac—Insomnia—Methotrexate—lymphatic system cancer	9.67e-05	0.000352	CcSEcCtD
Diclofenac—Paraesthesia—Methotrexate—lymphatic system cancer	9.6e-05	0.000349	CcSEcCtD
Diclofenac—Dyspnoea—Methotrexate—lymphatic system cancer	9.53e-05	0.000347	CcSEcCtD
Diclofenac—Somnolence—Methotrexate—lymphatic system cancer	9.5e-05	0.000346	CcSEcCtD
Diclofenac—Dyspepsia—Methotrexate—lymphatic system cancer	9.41e-05	0.000342	CcSEcCtD
Diclofenac—Decreased appetite—Methotrexate—lymphatic system cancer	9.29e-05	0.000338	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	9.23e-05	0.000336	CcSEcCtD
Diclofenac—Fatigue—Methotrexate—lymphatic system cancer	9.22e-05	0.000335	CcSEcCtD
Diclofenac—Pain—Methotrexate—lymphatic system cancer	9.14e-05	0.000332	CcSEcCtD
Diclofenac—Feeling abnormal—Methotrexate—lymphatic system cancer	8.81e-05	0.00032	CcSEcCtD
Diclofenac—Gastrointestinal pain—Methotrexate—lymphatic system cancer	8.74e-05	0.000318	CcSEcCtD
Diclofenac—Urticaria—Methotrexate—lymphatic system cancer	8.49e-05	0.000309	CcSEcCtD
Diclofenac—Abdominal pain—Methotrexate—lymphatic system cancer	8.45e-05	0.000307	CcSEcCtD
Diclofenac—Body temperature increased—Methotrexate—lymphatic system cancer	8.45e-05	0.000307	CcSEcCtD
Diclofenac—Hypersensitivity—Methotrexate—lymphatic system cancer	7.87e-05	0.000286	CcSEcCtD
Diclofenac—Asthenia—Methotrexate—lymphatic system cancer	7.67e-05	0.000279	CcSEcCtD
Diclofenac—Pruritus—Methotrexate—lymphatic system cancer	7.56e-05	0.000275	CcSEcCtD
Diclofenac—Diarrhoea—Methotrexate—lymphatic system cancer	7.31e-05	0.000266	CcSEcCtD
Diclofenac—Dizziness—Methotrexate—lymphatic system cancer	7.07e-05	0.000257	CcSEcCtD
Diclofenac—Vomiting—Methotrexate—lymphatic system cancer	6.8e-05	0.000247	CcSEcCtD
Diclofenac—Rash—Methotrexate—lymphatic system cancer	6.74e-05	0.000245	CcSEcCtD
Diclofenac—Dermatitis—Methotrexate—lymphatic system cancer	6.73e-05	0.000245	CcSEcCtD
Diclofenac—Headache—Methotrexate—lymphatic system cancer	6.7e-05	0.000244	CcSEcCtD
Diclofenac—Nausea—Methotrexate—lymphatic system cancer	6.35e-05	0.000231	CcSEcCtD
